BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26847311)

  • 41. The need for standardization of antiretinal antibody detection and measurement.
    Forooghian F; Macdonald IM; Heckenlively JR; Héon E; Gordon LK; Hooks JJ; Detrick B; Nussenblatt RB
    Am J Ophthalmol; 2008 Oct; 146(4):489-95. PubMed ID: 18672221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EFFECT OF PLASMAPHERESIS AND PASSAGE OF ANTI-RETINAL ANTIBODIES THROUGH THE PLACENTA IN A CASE OF NON-PARANEOPLASTIC AUTOIMMUNE RETINOPATHY.
    Sierpina DI; Skale DM; Fan JT
    Retin Cases Brief Rep; 2017 Winter; 11 Suppl 1():S34-S37. PubMed ID: 28009774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Unilateral manifestation of autoimmune retinopathy.
    Almeida DR; Chin EK; Niles P; Kardon R; Sohn EH
    Can J Ophthalmol; 2014 Aug; 49(4):e85-7. PubMed ID: 25103665
    [No Abstract]   [Full Text] [Related]  

  • 44. Assessment of Retinal Structural and Functional Characteristics in Eyes with Autoimmune Retinopathy.
    Sepah YJ; Sadiq MA; Hassan M; Hanout M; Soliman M; Agarwal A; Afridi R; Coupland SG; Nguyen QD
    Curr Mol Med; 2015; 15(6):578-86. PubMed ID: 26238366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
    Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
    Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autoimmune retinopathy.
    Comlekoglu DU; Thompson IA; Sen HN
    Curr Opin Ophthalmol; 2013 Nov; 24(6):598-605. PubMed ID: 24100366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome.
    Rizzo JF; Gittinger JW
    Ophthalmology; 1992 Aug; 99(8):1286-95. PubMed ID: 1325045
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Latest updates on antiretinal autoantibodies associated with vision loss and breast cancer.
    Adamus G
    Invest Ophthalmol Vis Sci; 2015 Mar; 56(3):1680-8. PubMed ID: 25754855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
    Guy J; Aptsiauri N
    Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo.
    Adamus G; Machnicki M; Elerding H; Sugden B; Blocker YS; Fox DA
    J Autoimmun; 1998 Oct; 11(5):523-33. PubMed ID: 9802939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells.
    Adamus G; Amundson D; Seigel GM; Machnicki M
    J Autoimmun; 1998 Dec; 11(6):671-7. PubMed ID: 9878089
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology.
    Mantel I; Ramchand KV; Holder GE; Ohbayashi M; Morohoshi K; Patel N; Toda M; Fitzke FW; Bird AC; Ono SJ
    Exp Mol Pathol; 2008 Apr; 84(2):90-101. PubMed ID: 18255057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Carcinoma-associated retinopathy in breast carcinoma and carcinoid tumor].
    Holz FG; Bellmann C; Steffen H; Nölle B; Huober J; Krastel H; Alexandridis E
    Ophthalmologe; 1997 May; 94(5):337-42. PubMed ID: 9273033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoimmune retinopathy.
    Braithwaite T; Vugler A; Tufail A
    Ophthalmologica; 2012; 228(3):131-42. PubMed ID: 22846442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy.
    Faez S; Loewenstein J; Sobrin L
    JAMA Ophthalmol; 2013 Jan; 131(1):113-5. PubMed ID: 23307224
    [No Abstract]   [Full Text] [Related]  

  • 56. A case of melanoma-associated retinopathy with autoantibodies against TRPM1.
    Kim MS; Hong HK; Ko YJ; Park KH; Ueno S; Okado S; Woo SJ; Joo K
    Doc Ophthalmol; 2020 Dec; 141(3):313-318. PubMed ID: 32472235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoantibody profiles and clinical association in Thai patients with autoimmune retinopathy.
    Pawestri AR; Arjkongharn N; Suvannaboon R; Tuekprakhon A; Srimuninnimit V; Udompunthurak S; Atchaneeyasakul LO; Koolvisoot A; Trinavarat A
    Sci Rep; 2021 Jul; 11(1):15047. PubMed ID: 34294798
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer associated retinopathy (CAR): An autoimmune-mediated paraneoplastic syndrome.
    Khan N; Huang JJ; Foster CS
    Semin Ophthalmol; 2006; 21(3):135-41. PubMed ID: 16912011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of Correlation between Number of Antiretinal Antibodies and Clinical Outcome Measures in Autoimmune Retinopathy Patients.
    Stanwyck LK; Moussa K; Chan W; Aitken PA; Sobrin L
    Ophthalmol Retina; 2019 Nov; 3(11):1007-1009. PubMed ID: 31420299
    [No Abstract]   [Full Text] [Related]  

  • 60. [Ocular paraneoplastic syndrome: cancer-associated retinopathy].
    Sampedro A; Carballo C; Barbón JJ; Andrés A; Viña C; Abelairas V
    Arch Soc Esp Oftalmol; 2013 Oct; 88(10):407-9. PubMed ID: 24060306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.